Short description

Guaifenazine 200 mg, novo-passit extract (hawthorn extract, hop extract, St. John's wort extract, lemon balm extract, passionflower extract, elderberry extract, valerian extract).
Pharmacological action: Anxiolytic, sedative.
Inside, adults and children over 12 years of age are prescribed 1 tab. 3 times / day before meals.
pharmachologic effect

Combined phytopreparation with a sedative effect, pharmacological activity is due to the components of the extract based on medicinal raw materials with a predominantly sedative effect and guaifenesin, which has an anxiolytic effect.
The sedative effect of the drug is complemented by the anxiolytic effect of guaifenesin.
Indications

    neurasthenia and neurotic reactions, accompanied by irritability, anxiety, fear, fatigue, absent-mindedness;
    manager syndrome; (a state of constant mental stress);
    insomnia (mild forms);
    headaches caused by nervous tension;
    migraine;
    functional gastrointestinal diseases (dyspeptic syndrome, irritable bowel syndrome);
    as a symptomatic agent for neurocirculatory dystonia and climacteric syndrome;
    itchy dermatoses (atopic and seborrheic eczema, urticaria) caused by psychological stress.

Method of administration and dosage

Inside, adults and children over 12 years of age are prescribed 1 tab. 3 times / day before meals. If necessary, according to the doctor's prescription, it is possible to increase the dose to 2 tab. 3 times / day In case of severe fatigue or depression, it is necessary to reduce the morning and afternoon dose to 1/2 tab. at the reception, in the evening take 1 tab. The interval between doses should be 4-6 hours.
In case of nausea, the drug should be taken with meals.

Side effects
From the digestive system: rarely - nausea, vomiting, cramps, heartburn, diarrhea, constipation.
From the side of the central nervous system: rarely - decreased concentration, dizziness, drowsiness.
Others: rarely - allergic reactions, exanthema, fatigue, slight muscle weakness. Symptoms quickly subside after discontinuation of the drug.
The patient should be warned that if these or other adverse reactions occur, it is necessary to consult a doctor.
Contraindications

myasthenia gravis;
children under 12 years of age;
hypersensitivity to the components of the drug.
The drug should be used with caution in patients with acute gastrointestinal diseases, liver diseases, chronic alcoholism, diseases and brain injuries, and epilepsy.
Overdose

Symptoms: at first - drowsiness, a feeling of depression, later - nausea, slight muscle weakness, joint pain, a feeling of heaviness in the stomach.
Treatment: gastric lavage, symptomatic therapy. The patient should be warned about the need to see a doctor.
special instructions

During the period of treatment with Novo-Passit, you should not drink alcohol.
The drug should be used with caution in acute gastrointestinal diseases.
The patient should be warned that if within 7 days of therapy the symptoms of the disease do not disappear or if they intensify, it is recommended to consult a doctor.
While taking Novo-Passit, you should avoid exposure to ultraviolet radiation (prolonged exposure to direct sunlight, visiting a solarium), especially for patients with fair skin.

Influence on the ability to drive vehicles and control mechanisms
During the period of treatment, it is necessary to refrain from engaging in potentially hazardous activities that require increased concentration of attention and speed of psychomotor reactions. You should not drive vehicles and mechanisms.
Interaction with other drugs

With the simultaneous administration of the drug Novo-Passit and other drugs, their effect can be enhanced or weakened. Before taking the drug concurrently with other drugs, the patient should consult a doctor.
The drug enhances the effect of ethanol and other substances that have a depressing effect on the central nervous system.
Medicines used to relax skeletal muscles (central muscle relaxation) may increase the risk of side effects of the drug, in

first of all - muscle weakness.
The extract of the herb St. John's wort contained in the preparation reduces the effectiveness of hormonal contraception, as well as drugs used mainly after transplantation to reduce the risk of rejection of the transplanted organ or tissue (immunosuppressants), drugs for the treatment of AIDS, cardiovascular diseases, bronchial diseases and the prevention of thromboembolism ... Therefore, before taking the drug Novo-Passit against the background of these drugs, the patient should consult a doctor.
Compound

Active ingredients:
powder of rhizomes with valerian roots - 25 mg,
powder of rhizomes with cyanosis roots - 10 mg,
motherwort extract - 10 mg,
lemon balm extract - 10 mg,
ascorbic acid (vitamin C) - 8 mg;
Excipients:
lactose,
methylcellulose,
calcium stearate,
talc,
twin 80,
titanium dioxide
food dyes.
Storage conditions

The drug should be stored out of the reach of children, protected from light at a temperature of 10 ° to 25 ° C. The shelf life of the tablets is 3 years. The shelf life of the solution for oral administration in vials is 4 years.